Filing Details

Accession Number:
0000950170-25-010121
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-28 20:39:01
Reporting Period:
2025-01-28
Accepted Time:
2025-01-28 20:39:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422143 Kura Oncology Inc. KURA Pharmaceutical Preparations (2834) 611547851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2051106 Mollie Leoni C/O Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego CA 92130
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-01-28 2,253 $7.87 90,963 No 4 S Direct
Common Stock Disposition 2025-01-28 1,353 $7.87 89,610 No 4 S Direct
Common Stock Disposition 2025-01-28 816 $7.87 88,794 No 4 S Direct
Common Stock Disposition 2025-01-28 541 $7.87 88,253 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
  2. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
  3. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
  4. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21.